Lithium Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Alzamend Neuro Announces Positive Phase IIA Clinical Trial Results for AL001
Topline data identifies maximum tolerated dose from Phase IIA multiple ascending dose study as assessed by an independent safety review committee Identified dose is unlikely to require lithium therapeutic drug monitoring Alzamend plans two Phase... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 22, 2023 Category: Pharmaceuticals Source Type: clinical trials

Melatonin and Response to Lithium
Condition:   Bipolar Disorder I Interventions:   Diagnostic Test: urine collection;   Diagnostic Test: Level of Protein 14.3.3;   Diagnostic Test: Level of miR-451 Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials